India Indicates Plan To Ease Pharma FDI Restraints To Keep Prices Lower
This article was originally published in PharmAsia News
Executive Summary
India Prime Minister Manmohan Singh appears indicated in a Cabinet meeting a preference for freeing the pharmaceutical industry from limits on foreign direct investment, sources said.